-+ 0.00%
-+ 0.00%
-+ 0.00%

Zentalis Pharma director Shannon Campbell files initial beneficial ownership statement

PUBT·05/27/2026 20:11:03
Listen to the news
Zentalis Pharma director Shannon Campbell files initial beneficial ownership statement
  • Zentalis Pharmaceuticals director Shannon Campbell filed an initial Form 3 statement of beneficial ownership dated May 22, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002018966-26-000004), on May 27, 2026, and is solely responsible for the information contained therein.